Sheldon Morris
University of California, San Diego
H-index: 40
North America-United States
Top articles of Sheldon Morris
No observed bidirectional effect between tenofovir diphosphate concentrations and gender‐affirming hormone concentrations among transgender persons switching from tenofovir …
British Journal of Clinical Pharmacology
2024/4/22
Sheldon Morris
H-Index: 27
RNA Editing ADAR1 Deaminase Activation Responsive (READAR) platforms for dynamic detection of clonal myeloproliferative neoplasm stem cell fitness
Cancer Research
2024/3/22
Sheldon Morris
H-Index: 27
Catriona Jamieson
H-Index: 37
HIV-1 Incidence, Adherence, and Drug Resistance in Individuals Taking Daily Emtricitabine/Tenofovir Disoproxil Fumarate for HIV-1 Pre-Exposure Prophylaxis: Pooled Analysis From …
Clinical Infectious Diseases
2024/3/14
Determinants of HIV Pre-Exposure Prophylaxis (PrEP) Retention among Transgender Women: A Sequential, Explanatory Mixed Methods Study
International Journal of Environmental Research and Public Health
2024/1/25
Facilitators of PrEP persistence among Black and Latinx transgender women in a PrEP Demonstration Project in Southern California
Behavioral Medicine
2024/1/2
Adedotun Ogunbajo
H-Index: 11
Sheldon Morris
H-Index: 27
Accelerated Hematopoietic Stem Cell Aging in Space
bioRxiv
2024
Gender-based violence and post-traumatic stress disorder symptoms predict HIV PrEP uptake and persistence failure among transgender and non-binary persons participating in a …
AIDS and Behavior
2023/2
1546. Relationship between Measured Glomerular Filtration Rate and Tenofovir Dried Blood Spot Concentrations among Transgender Adults on Tenofovir Alafenamide/Emtricitabine for …
Open Forum Infectious Diseases
2023/12
Sheldon Morris
H-Index: 27
Whole-Genome Sequencing to Predict Antimicrobial Susceptibility Profiles in Neisseria gonorrhoeae
The Journal of Infectious Diseases
2023/4/1
Sheldon Morris
H-Index: 27
Paul C Adamson
H-Index: 6
Nireshni Mitchev
H-Index: 3
Koleka Mlisana
H-Index: 34
Impact of (recurrent) bacterial vaginosis on quality of life and the need for accessible alternative treatments
BMC women's health
2023/3/18
Efficacy of daily text messaging to support adherence to HIV pre-exposure prophylaxis (PrEP) among stimulant-using men who have sex with men
Substance use & misuse
2023/2/23
Randomized trial of individualized texting for adherence building (iTAB) plus motivational interviewing for PrEP adherence in transgender individuals: The iM-PrEPT study
JAIDS Journal of Acquired Immune Deficiency Syndromes
2022/12/15
2080. Differences in Hormonal Measures Among Transgender Individuals Assigned Male at Birth Switching from Tenofovir Disoproxil Fumarate/Emtricitabine to Tenofovir Alafenamide …
Open Forum Infectious Diseases
2022/12/1
Sheldon Morris
H-Index: 27
Patient and physician preferences regarding long-acting pre-exposure prophylaxis and antiretroviral therapy: a mixed-methods study in Southern California, USA
AIDS research and human retroviruses
2022/11/1
Sheldon Morris
H-Index: 27
Sex differences in cytokine profiles during suppressive antiretroviral therapy
Aids
2022/7/15
Alan Wells
H-Index: 7
Sheldon Morris
H-Index: 27
COVID-19 vaccination elicits an evolving, cross-reactive antibody response to epitopes conserved with endemic coronavirus spike proteins
Cell reports
2022/7/5
Low incidence and prevalence of hepatitis C in two cohorts of HIV pre‐exposure prophylaxis adherence interventions in men who have sex with men in Southern California
Journal of viral hepatitis
2022/7
Sustained effect of LACTIN-V (Lactobacillus crispatus CTV-05) on genital immunology following standard bacterial vaginosis treatment: results from a randomised, placebo …
The Lancet Microbe
2022/6/1
Method of calculating renal function estimates could inappropriately exclude transgender patients receiving gender-affirming hormone therapy from pre-exposure prophylaxis …
LGBT health
2022/4/1
Sheldon Morris
H-Index: 27
Genital inflammation is not associated with decreased vaginal tenofovir concentrations in women taking oral PrEP
JAIDS Journal of Acquired Immune Deficiency Syndromes
2022/4/1
